Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 5-(acetylamino)-4-((aminoiminomethyl)amino)-2,6-anhydro-3,4,5-trideoxy-7-o-methyl-d-glycero-d-galacto-non-2-enonic Acid
2. Laninamivir
3. Laninamivir Octanoate
4. Laninamivir Octanoate Hydrate
5. Laninamivir Trifluoroacetate
6. R 125489
7. R-125489
8. R125489
1. Mcg28bi87w
2. 1233643-88-3
3. Inavir
4. Laninamivir Octanoate Hydrate
5. Laninamivir Octanoate Hydrate (jan)
6. Laninamivir Octanoate Hydrate [jan]
7. Unii-mcg28bi87w
8. Schembl17728099
9. Dtxsid70153991
10. Laninamivir Octanoate Hydrate, (+)-
11. D09547
12. Laninamivir Octanoate Monohydrate [who-dd]
13. Laninamivir Octanoic Acid Ester Hydrate [mi]
14. Q27283864
15. (2r,3r,4s)-3-acetamido-4-guanidino-2-((1r,2r)-2-hydroxy-1-methoxy-3-(octanoyloxy)propyl)-3,4-dihydro-2h-pyran-6-carboxylic Acid Monohydrate
| Molecular Weight | 490.5 g/mol |
|---|---|
| Molecular Formula | C21H38N4O9 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 15 |
| Exact Mass | 490.26387880 g/mol |
| Monoisotopic Mass | 490.26387880 g/mol |
| Topological Polar Surface Area | 197 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 723 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Antiviral Agents
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)
Global Sales Information
ABOUT THIS PAGE
A Laninamivir Octanoate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Laninamivir Octanoate, including repackagers and relabelers. The FDA regulates Laninamivir Octanoate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Laninamivir Octanoate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Laninamivir Octanoate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Laninamivir Octanoate supplier is an individual or a company that provides Laninamivir Octanoate active pharmaceutical ingredient (API) or Laninamivir Octanoate finished formulations upon request. The Laninamivir Octanoate suppliers may include Laninamivir Octanoate API manufacturers, exporters, distributors and traders.
click here to find a list of Laninamivir Octanoate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Laninamivir Octanoate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Laninamivir Octanoate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Laninamivir Octanoate GMP manufacturer or Laninamivir Octanoate GMP API supplier for your needs.
A Laninamivir Octanoate CoA (Certificate of Analysis) is a formal document that attests to Laninamivir Octanoate's compliance with Laninamivir Octanoate specifications and serves as a tool for batch-level quality control.
Laninamivir Octanoate CoA mostly includes findings from lab analyses of a specific batch. For each Laninamivir Octanoate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Laninamivir Octanoate may be tested according to a variety of international standards, such as European Pharmacopoeia (Laninamivir Octanoate EP), Laninamivir Octanoate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Laninamivir Octanoate USP).
LOOKING FOR A SUPPLIER?
